Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital

References

• Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol 2008; 18: 228–39
   PubMed Web of Science ®Google Scholar
• Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld FC, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 66: 34–45
   PubMed Web of Science ®Google Scholar
• Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762–84
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 2002; 41: 1367–74
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Chung CP, Stein CM, Mitchel EF, Jr, Griffin MR. Changing patterns of medication use in patients with rheumatoid arthritis in a medicaid population. Rheumatology (Oxford) 2008; 47: 1061–4
   PubMedGoogle Scholar
• Nikolaisen, C, Kvien, TK, Mikkelsen, K, Kaufmann, C, Rodevand, E, Nossent, JC. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway. Scand J Rheumatol 2009, [Epub ahead of print]. DOI 10.1080/03009740802609566.
   PubMedGoogle Scholar
• Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006; 54: 1401–9
   PubMed Web of Science ®Google Scholar
• Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111: 446–51
   PubMed Web of Science ®Google Scholar
• van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with ‘second-line’ antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996; 124: 699–707
   PubMed Web of Science ®Google Scholar
• Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008; 67: 815–22
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66: 1491–6
   PubMed Web of Science ®Google Scholar
• Kiely, P, Williams, R, Walsh, D, Young, A, for the Early Rheumatoid Arthritis Network (ERAN). Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford) 2009;48:57–60.
   PubMed Web of Science ®Google Scholar
• Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000; 43: 22–9
   PubMed Web of Science ®Google Scholar
• Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K. Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 2008; 29: 411–15
   PubMedGoogle Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263–8
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005; 92: 594–6
   PubMedGoogle Scholar
• Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003; 88: 1687–92
   PubMed Web of Science ®Google Scholar
• Introduction to drug utilization research. OsloNorway, World Health Organization, 2003, http://www.whocc.no/atcddd/ (accessed 18 August 2009).
   Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–83
   PubMedGoogle Scholar
• de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003; 56: 221–9
   PubMed Web of Science ®Google Scholar
• Singh JA, Holmgren AR, Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 2004; 51: 952–7
   PubMedGoogle Scholar
• Christiansen JU, Maruard CD, Nielsen HC. LABKA. A real-time computer system for the clinical laboratory. Scand J Clin Lab Invest Suppl 1989; 194: 57–61
   PubMedGoogle Scholar
• The Danish National Board of Health. The Danish Institute for Health Technology Assessment. Rheumatoid arthritis – a medical technology assessment of diagnosis and treatment. Health Technology Assessment. 2002:4, (summary in English)http://www.sst.dk/publ/Publ2003/SST_leddeg_AS5.pdf(accessed 18 August 2009).
   Google Scholar
• Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, Van Staa TP, et al. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom general practice research database. Rheumatology (Oxford) 2005; 44: 1394–8
   PubMedGoogle Scholar
• Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 2004; 63: 1269–75
   PubMed Web of Science ®Google Scholar
• Nikolaisen C, Figenschau Y, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008; 35: 380–6
   PubMed Web of Science ®Google Scholar
• Gotzsche, PC, Johansen, HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 2004, 3, D000189
   Google Scholar
• Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, et al. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007; 57: 928–34
   PubMed Web of Science ®Google Scholar
• Kremer JM, Alarcon GS, Lightfoot RW, Jr, Willkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994; 37: 316–28
   PubMed Web of Science ®Google Scholar
• Pedersen M, Klarlund M, Jacobsen S, Svendsen AJ, Frisch M. Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol 2004; 19: 1097–103
   PubMed Web of Science ®Google Scholar
• Singh JA, Holmgren AR, Noorbaloochi S. Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum. 2004; 0(6)952–7
   Google Scholar
• Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 2004; 34: 423–6
   PubMed Web of Science ®Google Scholar